These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17095638)

  • 1. Higher antibody, but not cell-mediated, responses to vaccination in high physically fit elderly.
    Keylock KT; Lowder T; Leifheit KA; Cook M; Mariani RA; Ross K; Kim K; Chapman-Novakofski K; McAuley E; Woods JA
    J Appl Physiol (1985); 2007 Mar; 102(3):1090-8. PubMed ID: 17095638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4 T-helper cell cytokine phenotypes and antibody response following tetanus toxoid booster immunization.
    Livingston KA; Jiang X; Stephensen CB
    J Immunol Methods; 2013 Apr; 390(1-2):18-29. PubMed ID: 23318779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses to tetanus vaccination in Italian healthy subjects and children with recurrent infections.
    Graziani S; Romiti ML; Capponi C; Di Cesare S; Corrente S; Monteferrario E; Di Paolo A; De Marchis C; Chini L; Moschese V
    J Biol Regul Homeost Agents; 2013; 27(1):95-103. PubMed ID: 23489690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine synthesis analyzed at the single-cell level before and after revaccination with tetanus toxoid.
    Fernandez V; Andersson J; Andersson U; Troye-Blomberg M
    Eur J Immunol; 1994 Aug; 24(8):1808-15. PubMed ID: 8056039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise and psychosocial factors modulate immunity to influenza vaccine in elderly individuals.
    Kohut ML; Cooper MM; Nickolaus MS; Russell DR; Cunnick JE
    J Gerontol A Biol Sci Med Sci; 2002 Sep; 57(9):M557-62. PubMed ID: 12196490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetanus Toxoid carrier protein induced T-helper cell responses upon vaccination of middle-aged adults.
    van der Heiden M; Duizendstra A; Berbers GAM; Boots AMH; Buisman AM
    Vaccine; 2017 Oct; 35(42):5581-5588. PubMed ID: 28882444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired responses of peripheral blood mononuclear cells to nickel in patients with nickel-allergic contact dermatitis and concomitant atopic dermatitis.
    Buchvald D; Lundeberg L
    Br J Dermatol; 2004 Mar; 150(3):484-92. PubMed ID: 15030331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High interleukin-10 production is associated with low antibody response to influenza vaccination in the elderly.
    Corsini E; Vismara L; Lucchi L; Viviani B; Govoni S; Galli CL; Marinovich M; Racchi M
    J Leukoc Biol; 2006 Aug; 80(2):376-82. PubMed ID: 16707559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of intracellular antigen-specific cytokines in human T cell populations.
    Kallas EG; Gibbons DC; Soucier H; Fitzgerald T; Treanor JJ; Evans TG
    J Infect Dis; 1999 May; 179(5):1124-31. PubMed ID: 10191213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
    Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
    Arthritis Rheum; 2009 Aug; 60(8):2438-47. PubMed ID: 19644961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an adult-like cell-mediated immune response in calves after early vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
    Nonnecke BJ; Waters WR; Foote MR; Palmer MV; Miller BL; Johnson TE; Perry HB; Fowler MA
    J Dairy Sci; 2005 Jan; 88(1):195-210. PubMed ID: 15591383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T-cell responses to Trichophyton tonsurans: inhibition using the serum free medium Aim V.
    Slunt JB; Taketomi EA; Platts-Mills TA
    Clin Exp Allergy; 1997 Oct; 27(10):1184-92. PubMed ID: 9383259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of probiotic supplementation for the first 6 months of life on allergen- and vaccine-specific immune responses.
    Taylor AL; Hale J; Wiltschut J; Lehmann H; Dunstan JA; Prescott SL
    Clin Exp Allergy; 2006 Oct; 36(10):1227-35. PubMed ID: 17014429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peanut-specific B and T cell responses are correlated in peanut-allergic but not in non-allergic individuals.
    Turcanu V; Winterbotham M; Kelleher P; Lack G
    Clin Exp Allergy; 2008 Jul; 38(7):1132-9. PubMed ID: 18564333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of congestive heart failure on humoral and ex vivo cellular immune responses to influenza vaccination in older adults.
    McElhaney JE; Herre JM; Lawson ML; Cole SK; Burke BL; Hooton JW
    Vaccine; 2004 Jan; 22(5-6):681-8. PubMed ID: 14741160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced humoral and Type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsion.
    Baldwin SL; Shaverdian N; Goto Y; Duthie MS; Raman VS; Evers T; Mompoint F; Vedvick TS; Bertholet S; Coler RN; Reed SG
    Vaccine; 2009 Oct; 27(43):5956-63. PubMed ID: 19679214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced IL-4 associated antibody responses to vaccine in early pre-diabetes.
    Schmid S; Molteni A; Füchtenbusch M; Naserke HE; Ziegler AG; Bonifacio E
    Diabetologia; 2002 May; 45(5):677-85. PubMed ID: 12107748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.